Zeyuan Yu

5PUBLICATIONS
43CO-AUTHORS
Molecular targetsCancer diagnosisCancer cell biologyChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 23, 2026
Non-kinase Orchestrated VEGFR2-ERK Signaling is a Dependency and Pharmacological Target for Antiangiogenic Immunotherapy.

|Nov 06, 2025
USP20-Driven Cholesterol Metabolism Links Inflammatory Signaling to Malignancy and Stromal Coevolution in Pancreatic Cancer.

Xiangyan Jiang, Bin Zhao, Tao Wang

|Sep 23, 2024
Targeting SHCBP1 Inhibits Tumor Progression by Restoring Ciliogenesis in Ductal Carcinoma.

Wengui Shi, Lianshun Li, Huiming Zhao

|Jan 26, 2024
Targeted Mevalonate Pathway and Autophagy in Antitumor Immunotherapy.

Zongrui Xing, Xiangyan Jiang, Yuxia Wu

|Aug 30, 2023
PICH Activates Cyclin A1 Transcription to Drive S-Phase Progression and Chemoresistance in Gastric Cancer.

Huili Ye, Wengui Shi, Jing Yang

Pageof 1

Frequent Collaborators

4 joint publications

Wengui Shi

4 joint publications

Xiangyan Jiang

4 joint publications

Long Qin

4 joint publications

Zuoyi Jiao